Xylocaine Injection, Solution
Product Images NDC 63323-492

Product Visual Gallery

This gallery contains 18 technical images submitted to the FDA as part of the official labeling for Xylocaine (NDC 63323-492). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Xyl02 0001 01

Chemical structure diagram of Lidocaine Hydrochloride, the active ingredient shown in the Xylocaine injection solution. The structure depicts the molecular arrangement of atoms including aromatic rings and functional groups characteristic of lidocaine.*

FDA Label Image

Xyl02 0001 02

Chemical structure diagram depicting the molecular structure of the active ingredient in Xylocaine, lidocaine hydrochloride, showing aromatic rings and functional groups consistent with lidocaine.*

FDA Label Image

Xyl02 0001 03

FDA Label Image

Xyl02 0001 04

FDA Label Image

Xyl02 0001 05

Xylocaine injection label for lidocaine HCl and epinephrine injection, USP, with epinephrine 1:100,000. The solution strength is 1% lidocaine (10 mg/mL) with 200 mg per 20 mL vial. Indicated for infiltration and nerve block, not for caudal or epidural use. Multiple dose vial, Rx only, manufactured by Fresenius Kabi USA, LLC.*

FDA Label Image

Xyl02 0001 06

Label for Xylocaine Injection, USP with Epinephrine 1:100,000, containing Lidocaine HCl 10 mg/mL and Epinephrine 0.01 mg/mL. This 1% injection solution is supplied in 25 multiple-dose 20 mL vials for infiltration and nerve block, not for caudal or epidural use. Manufactured by Fresenius Kabi USA, LLC.*

FDA Label Image

Xyl02 0001 07

Label for Xylocaine (lidocaine HCl injection, USP) 1% solution, 20 mL multiple dose vial. The label specifies 200 mg per 20 mL (10 mg per mL) strength for infiltration and nerve block, not for caudal or epidural use. It is a prescription injection solution manufactured by Fresenius Kabi USA, LLC in Lake Zurich, IL.*

FDA Label Image

Xyl02 0001 08

Label for Xylocaine (lidocaine HCl injection, USP) 1% solution, 200 mg per 20 mL vial (10 mg/mL). It is intended for infiltration and nerve block, not for caudal or epidural use. The label indicates 25 multiple dose vials of 20 mL each, manufactured by Fresenius Kabi USA, LLC. The solution is sterile and nonpyrogenic with listed ingredients and storage instructions.*

FDA Label Image

Xyl02 0001 09

Xylocaine 2% lidocaine HCl injection, USP 20 mL multiple dose vial label by Fresenius Kabi. Contains 400 mg per 20 mL (20 mg/mL) for infiltration and nerve block use. Not for caudal or epidural use. Sterile, nonpyrogenic with storage instructions and manufacturer information.*

FDA Label Image

Xyl02 0001 10

Xylocaine 2% (lidocaine HCl injection, USP) injection solution with 400 mg per 20 mL (20 mg/mL) strength. Displayed on a multi-dose vial label containing 25 vials of 20 mL each. Manufactured by Fresenius Kabi USA, for infiltration and nerve block use, not for caudal or epidural use. The label includes formulation ingredients, storage instructions, and regulatory information.*

FDA Label Image

Xyl02 0001 11

Label for Xylocaine-MPF lidocaine HCl injection, USP 1% solution, delivering 20 mg per 2 mL (10 mg per mL). It is intended for infiltration and nerve block, including caudal and epidural use. The product is a 2 mL single dose vial manufactured by Fresenius Kabi USA, LLC in Lake Zurich, Illinois.*

FDA Label Image

Xyl02 0001 12

Xylocaine-MPF 1% (lidocaine HCl injection, USP) 20 mg per 2 mL (10 mg per mL) single dose vials. This sterile, nonpyrogenic injection solution contains 10 mg lidocaine HCl and 7 mg sodium chloride per mL, with pH adjusted to approximately 6.5. Labeled for infiltration and nerve block including caudal and epidural use, methylparaben free, Rx only. Manufactured by Fresenius Kabi USA, LLC with storage instructions at 20° to 25°C.*

FDA Label Image

Xyl02 0001 13

Label for Xylocaine-MPF (lidocaine HCl injection, USP) 1% solution, providing 50 mg per 5 mL (10 mg per mL) in a 5 mL single-dose vial. Intended for infiltration and nerve block, including caudal and epidural use. Methylparaben free. Manufactured by Fresenius Kabi USA, LLC.*

FDA Label Image

Xyl02 0001 14

Xylocaine-MPF (lidocaine HCl injection, USP) 1% solution, 10 mg/mL strength, for infiltration and nerve block including caudal and epidural use. The label indicates 25 single dose 5 mL vials per package. It is methylparaben free, sterile, and nonpyrogenic. Manufactured by Fresenius Kabi USA, LLC in Lake Zurich, IL.*

FDA Label Image

Xyl02 0001 15

Label for Xylocaine-MPF (lidocaine HCl injection, USP) 2% solution, providing 100 mg per 5 mL (20 mg/mL) in a 5 mL single dose vial. Indicated for infiltration and nerve block including caudal and epidural use. Methylparaben free. Manufactured by Fresenius Kabi USA, LLC, Lake Zurich, IL.*

FDA Label Image

Xyl02 0001 16

Xylocaine-MPF 2% (lidocaine HCl injection, USP) solution label showing 20 mg/mL strength for infiltration and nerve block including caudal and epidural use. The label indicates methylparaben free, 25 single-dose 5 mL vials, and manufactured by Fresenius Kabi USA, LLC. Storage at 20° to 25°C and sterile, nonpyrogenic conditions are noted.*

FDA Label Image

Xyl02 0001 17

Xylocaine-MPF (lidocaine HCl Injection, USP) 1% solution, 300 mg per 30 mL (10 mg per mL), in a 30 mL single dose vial. For infiltration and nerve block including caudal and epidural use, methylparaben free. Label indicates it is sterile, nonpyrogenic, can be resterilized by autoclaving, and should be stored at 20° to 25°C. Manufactured by Fresenius Kabi USA, LLC.*

FDA Label Image

Xyl02 0001 18

Xylocaine-MPF 1% (lidocaine HCl injection, USP) label for a 300 mg per 30 mL (10 mg per mL) concentration. The sterile, nonpyrogenic solution is intended for infiltration and nerve block, including caudal and epidural use. The package contains 25 single-dose vials of 30 mL each, labeled methylparaben-free. Manufactured by Fresenius Kabi USA, LLC, with storage instructions and ingredient details also noted.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.